Patents Assigned to MEDICAL UNIVERSITY OF GRAZ
  • Patent number: 10870887
    Abstract: Described are methods and kits for identifying a subject at risk of, or having, a sensory neuropathy related disease, such as sensory neuropathies. In particular, the disclosure is based on the determination of mutations in the SPTLC2 gene causing sensory neuropathies.
    Type: Grant
    Filed: November 16, 2017
    Date of Patent: December 22, 2020
    Assignees: VIB VZW, UNIVERSITEIT ANTWERPEN, UNIVERSITY OF ZURICH, MEDICAL UNIVERSITY OF GRAZ
    Inventors: Annelies Rotthier, Vincent Timmerman, Michaela Auer-Grumbach, Thorsten Hornemann
  • Publication number: 20180155790
    Abstract: Described are methods and kits for identifying a subject at risk of, or having, a sensory neuropathy related disease, such as sensory neuropathies. In particular, the disclosure is based on the determination of mutations in the SPTLC2 gene causing sensory neuropathies.
    Type: Application
    Filed: November 16, 2017
    Publication date: June 7, 2018
    Applicants: VIB VZW, UNIVERSITEIT ANTWERPEN, UNIVERSITY OF ZURICH, MEDICAL UNIVERSITY OF GRAZ
    Inventors: Annelies Rotthier, Vincent Timmerman, Michaela Auer-Grumbach, Thorsten Hornemann
  • Patent number: 9828638
    Abstract: Described are methods and kits for identifying a subject at risk of, or having, a sensory neuropathy related disease, such as sensory neuropathies. In particular, the disclosure is based on the determination of mutations in the SPTLC2 gene causing sensory neuropathies.
    Type: Grant
    Filed: September 19, 2011
    Date of Patent: November 28, 2017
    Assignees: VIB VZW, Universiteit Antwerpen, University of Zurich, Medical University of Graz
    Inventors: Annelies Rotthier, Vincent Timmerman, Michaela Auer-Grumbach, Thorsten Hornemann
  • Patent number: 8962008
    Abstract: The present invention relates to a novel polymeric material with enhanced hydrophilicity for medical use comprising a biocompatible polyester material selected from the group consisting of poly(hydroxyalkanoate)s, poly(lactic acid)s, poly(glycolic acid)s, poly(caprolactone)s and copolymers and blends thereof, wherein the biocompatible polyester material is crosslinked with a functionalized poly(alkylene oxide) having at least two functional groups independently selected from the group consisting of azido-formate and alkanoyl azide. The novel polymeric material with enhanced hydrophilicity is useful as a biocompatible material in a variety of medical applications, including medical implants, bioresorbable implants, tissue engineering, and controlled release.
    Type: Grant
    Filed: June 20, 2012
    Date of Patent: February 24, 2015
    Assignees: Technische Universitat Graz, Medical University of Graz MUG, AT&S Austria Technologie & Systemtechnik Aktiengesellschaft, Herabus Medical GmbH
    Inventors: Frank Wiesbrock, Clemens Ebner, Franz Stelzer, Annelie-Martina Weinberg, Klaus-Dieter Kühn
  • Publication number: 20120276632
    Abstract: The present invention provides a cell culture medium supplement comprising plasma-free platelet lysate and medium supplemented with this supplement. The present invention further provides a method for preparing the supplement comprising the steps of (a) preparing platelet rich plasma; (b) removing the plasma; and (c) lysing the platelets.
    Type: Application
    Filed: May 30, 2012
    Publication date: November 1, 2012
    Applicant: MEDICAL UNIVERSITY OF GRAZ
    Inventors: Dirk Strunk, Katharina Schallmoser, Eva Rohde